FDA Inspection 949464 — Rommelag CDMO GmbH
The FDA completed an inspection of Rommelag CDMO GmbH on October 22, 2015 in Sulzbach-Laufen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 22, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sulzbach-Laufen (Germany)